Changqin Pu

Dr. Changqin Pu earned dual Bachelor’s degrees in Clinical Medicine (Nanchang University) and Biomedical Science (Queen Mary University of London) with First-Class Honours. Currently training at the Chinese Academy of Medical Sciences, his research integrates single-cell transcriptomics (Institute of Genetics and Developmental Biology, CAS) to decode pituitary adenoma heterogeneity and machine learning-driven prognostic models for glioblastoma (Nanchang University). Awarded the Global 100 "Leaders of Tomorrow in Biomedicine" (GBD, 2022) and Gold Medals at the International "Internet Plus" Innovation Competition (2021, 2022), he has published 6 SCI papers on neuro-oncology and psychiatric informatics, alongside patented innovations in emergency medical systems. His work bridges computational biology with precision oncology.